Pulmonary Regurgitation - Results from the Harmony™ Transcatheter Pulmonary Valve Trial
- PMID: 36276507
- PMCID: PMC9524622
- DOI: 10.17925/HI.2020.14.2.67
Pulmonary Regurgitation - Results from the Harmony™ Transcatheter Pulmonary Valve Trial
Keywords: Harmony; Pulmonary regurgitation; right ventricular outflow tract; tetralogy of Fallot; transcatheter.
Conflict of interest statement
Disclosures: John Cheatham is a consultant, proctor and the national principal investigator for Medtronic.
References
-
- Hoffman JL, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39:1890–900. - PubMed
-
- Bergersen L, Benson LN, Gillespie MJ. et al. Harmony feasibility trial: acute and short-term outcomes with a self-expanding transcatheter pulmonary valve. JACC Cardiovasc Interv. 2017;10:1763–73. - PubMed
-
- Benson LN, Gillespie MJ, Bergersen L. et al. Three-year outcomes from the Harmony native outflow tract early feasibility study. Circ Cardiovasc Interv. 2020;13:e008320. - PubMed
-
- Bonhoeffer P, Boudjemline Y, Saliba Z. et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet. 2000;356:1403–5. - PubMed
-
- ClinicalTrials.gov. The Medtronic Harmony™ Transcatheter Pulmonary Valve Clinical Study. Available at: www.clinicaltrials.gov/ct2/show/NCT02979587 (accessed 20 August 2020)
Publication types
LinkOut - more resources
Full Text Sources